相关实验视频

Updated: May 5, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

初级骨髓纤维化,呈现时血红蛋白度增加

Giovanni Barosi¹, Rita Campanelli¹, Paolo Catarsi¹

¹Center for the Study of Myelofibrosis, Scientific Direction, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy.

British journal of haematology

|June 24, 2025

概括

诊断时血红蛋白高的原发性髓纤维化 (PMF) 表明由JAK2 V617F驱动的独特,不那么炎症的亚型. 这种变种表现出更慢的进展和更长的生存期,影响了预后和治疗决策.

科学领域:

血液学血液学血液学
在瘤学瘤学.
遗传学遗传学是一个

背景情况:

原发性骨髓纤维化 (PMF) 是一种骨髓扩散性瘤.
诊断时的疾病特征会影响预后和治疗策略.
在PMF中血红蛋白度升高的作用仍然不完全理解.

研究的目的:

研究PMF患者在诊断时血红蛋白升高的临床特征和结果.
为了确定与这一特定的PMF亚组的生存相关的因素.
了解高血红蛋白对疾病进展和炎症的影响.

主要方法:

从帕维亚-CSM数据库对963名PMF患者的回顾性分析.
诊断时血红蛋白升高和不升高的患者之间的临床和分子特征的比较 (女性≥160 g/L,男性≥165 g/L).
评估疾病活动标志物,炎症,进展和生存.

主要成果:

100名患者 (10.4%) 在诊断时血红蛋白升高,主要是女性和年轻人.
这些患者的白细胞和血小板数量更高,JAK2 V617F变异基因频率 (VAF) 也更高.
他们表现出不太活跃的疾病 (脏较小,LDH较低,CD34+细胞较低,纤维化较少),炎症减少 (hs-CRP较低),进展缓慢到骨髓质形成症,生存时间更长 (22年 vs. 15年).
在这个小组中,年龄>50岁和JAK2 V617F VAF>75%与生存率较差相关.

结论:

在诊断时血红蛋白升高的PMF代表了一个独特的亚型,其特征是由JAK2 V617F驱动的过度增殖与减少炎症.
这种独特的表型与较少的侵袭性疾病过程和改善的生存率有关.
这些发现对PMF风险分层和治疗方法有重大影响.

关键词:

血液学的恶性瘤.骨髓纤维化骨髓纤维化骨髓增殖性疾病是一种骨髓增殖性疾病.维拉多细胞性血症 (Vera polycythaemia) 是一种疾病.

更多相关视频

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

相关概念视频

Erythropoiesis

Erythropoiesis

Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Disorders of Erythrocytes

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...